Related Experiment Video
Updated: May 19, 2026
06:52
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
The inflammasome in lung diseases
Gimena dos Santos1, Mikhail A Kutuzov, Karen M Ridge
1Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Summary
The inflammasome, an immune complex, drives lung inflammation in diseases like asthma and infections. Understanding its activation is key to treating respiratory conditions.
Area of Science:
- Immunology
- Respiratory Medicine
- Cellular Biology
Background:
- Uncontrolled inflammation can be more harmful than the initial injury.
- The inflammasome is an intracellular protein complex regulating IL-1 family cytokines.
- Emerging evidence links inflammasome activation to respiratory disease pathogenesis.
Purpose of the Study:
- To review the critical role of inflammasome activation in lung diseases.
- To summarize key aspects of inflammasome function in respiratory conditions.
Main Methods:
- Literature review focusing on inflammasome activation pathways.
- Analysis of studies involving respiratory pathogens and inflammatory lung diseases.
- Synthesis of current knowledge on inflammasome's role in conditions like asthma, COPD, and pulmonary fibrosis.
Main Results:
- The inflammasome is activated by common respiratory pathogens (e.g., influenza A virus, Streptococcus pneumoniae).
- It contributes to chronic airway inflammation in asthma and COPD.
- Inflammasome activation is implicated in the development of pulmonary fibrosis.
Conclusions:
- The inflammasome is a central mediator in various acute and chronic lung diseases.
- Targeting inflammasome pathways presents a potential therapeutic strategy for respiratory ailments.
More Related Videos
Related Concept Videos
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:26Acute Inflammation I: Inflammatory Response
Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...